Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Cancers|September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistoryMehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
Plos One|April 6, 2018
The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma GroupLionel Perrier, Pauline Rascle, Magali Morelle, et al.
Bulletin Du Cancer|February 22, 2014
[To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region]Yohan Fayet, Virginie Chasles, Françoise Ducimetière, et al.
Bulletin Du Cancer|September 20, 2011
Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective studyIrène Asmane, Jean-Emmanuel Kurtz, Agathe Bajard, et al.
Cancers|January 13, 2021
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, et al.
ESMO Open|November 28, 2020
Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatmentAlice Boilève, Armelle Dufresne, Ali Chamseddine, et al.
Anticancer Research|August 9, 2015
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for First Relapse of Ovarian CancerJean-Marc Classe, Olivier Glehen, Evelyne Decullier, et al.
Journal for Immunotherapy of Cancer|February 13, 2021
Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancerRomain Cohen, Vincent Jonchère, Christelle De La Fouchardière, et al.
The Lancet. Oncology|January 21, 2021
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trialFrançois Quénet, Dominique Elias, Lise Roca, et al.
BMC Cancer|March 7, 2014
Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma groupThanh-Khoa Huynh, Pierre Meeus, Philippe Cassier, et al.
Pageof 9